Mahkam Zanganeh
Co-Chief Executive Officer at Summit Therapeutics; Director at Pulse Biosciences. Based in Miami, Florida.
- Rank
- 795th of 14,452
- Companies held
- 2
- Largest holding
- SMMT, 83.5% of total
- Latest SEC filing
- Nov 16, 2026
- Listed but not counted
- $6.07B
What the $236M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Summit Therapeutics SMMT Common Stock | Through the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee Reported jointly by 2 insiders; split evenly | 12,912,237 | $10.57 | $136M | 57.9% | Form 4, Nov 16, 2026 |
| Summit Therapeutics SMMT Common Stock | Through the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee Reported jointly by 2 insiders; split evenly | 5,099,888 | $10.57 | $53.9M | 22.9% | Form 4, Nov 16, 2026 |
| Pulse Biosciences PLSE Common Stock | Directly | 725,395 | $44.41 | $32.2M | 13.7% | Form 4, Feb 3, 2025 |
| Summit Therapeutics SMMT Common Stock | Directly | 531,000 | $10.57 | $5.6M | 2.4% | Form 4, Nov 16, 2026 |
| Pulse Biosciences PLSE Common Stock | Immediate Family Member 3 | 107,074 | $44.41 | $4.8M | 2.0% | Form 4, Jan 24, 2025 |
| Pulse Biosciences PLSE Common Stock | Immediate Family Member 1 | 27,000 | $44.41 | $1.2M | 0.5% | Form 4, Jan 24, 2025 |
| Summit Therapeutics SMMT Common Stock | Immediate family member | 76,680 | $10.57 | $811K | 0.3% | Form 4, Nov 16, 2026 |
| Pulse Biosciences PLSE Common Stock | Immediate Family Member 2 | 14,000 | $44.41 | $622K | 0.3% | Form 4, Jan 24, 2025 |
Share counts are the amounts Mahkam Zanganeh reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Mahkam Zanganeh's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Summit Therapeutics SMMT Common Stock | Through Spouse Counted on the profile of the insider who holds these shares directly | 573,883,879 | $10.57 | $6.07B | — | Form 4, Nov 16, 2026 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 792 | Firat Ileri Director, BillionToOne | $236M |
| 793 | James E. Douglas III Insider, IMAX. Greenbrae, CA | $236M |
| 794 | Kevin Douglas Director, IMAX. Greenbrae, CA | $236M |
| 795 | Mahkam Zanganeh Co-Chief Executive Officer, Summit Therapeutics. Miami, FL | $236M |
| 796 | Donald J. Trump Jr. Director, Trump Media & Technology Group. Coppell, TX | $235M |
| 797 | Christopher R. Christensen Executive Chairman, The Ensign Group. Eagle, ID | $235M |
| 798 | Herald Y. Chen Director, AppLovin. Palo Alto, CA | $235M |
Other Summit Therapeutics insiders
All SMMT insiders- Robert W. Duggan$6.26BCo-Chief Executive Officer. #34 overall
- Yu Xia$339MDirector. #627 overall
- Manmeet Soni$34.1MCOO and CFO. #3414 overall
- Ankur Dhingra$4.2MChief Financial Officer. #6885 overall
Questions
How much stock does Mahkam Zanganeh own?
Mahkam Zanganeh holds $235,602,097 in listed stock based on SEC filings and current prices, mostly Summit Therapeutics (SMMT). That ranks 795th on the Stock Rich List.
Is this Mahkam Zanganeh's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Mahkam Zanganeh last buy or sell stock?
The most recent open-market trade on file is a purchase of 3,810,000 SMMT shares on Jun 12, 2026 at $13.12.